Compare Lustrum:KYORIN Pharmaceutical Co., Ltd.:4569

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index KYORIN Pharmaceutical Co., Ltd. Go to web site 4569 Medicals 東証プライム March 1, 2000 2006.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

KYORIN Pharmaceutical Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2023年3月期 KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2022年3月期 KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2021年3月期 KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2020年3月期 KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents
(Percent)
19,394down
(11.0%)down
26,994down
(15.7%)down
27,445down
(16.4%)down
31,925down
(18.7%)up
32,007
(18.5%)
Other Current AssetsHelp
(Percent)
99,636up
(56.6%)up
89,382up
(52.0%)up
86,582up
(51.8%)up
85,133up
(49.7%)up
82,897
(47.9%)
Tangible Fixed AssetsHelp
(Percent)
25,834up
(14.7%)up
24,334up
(14.2%)down
23,896up
(14.3%)up
22,721up
(13.3%)up
21,792
(12.6%)
Intangible Fixed AssetHelp
(Percent)
5,393up
(3.1%)up
3,289down
(1.9%)down
3,785up
(2.3%)up
3,332down
(1.9%)down
3,401
(2.0%)
Investments and OthersHelp
(Percent)
25,788down
(14.6%)down
27,925up
(16.2%)up
25,418down
(15.2%)down
28,049down
(16.4%)down
32,937
(19.0%)
Total AssetsHelp
(Percent)
176,045
(100%)
171,924
(100%)
167,126
(100%)
171,160
(100%)
173,034
(100%)
Total Current LiabilitiesHelp
(Percent)
39,741up
(22.6%)up
36,240up
(21.1%)up
31,020down
(18.6%)down
47,912down
(28.0%)down
49,263
(28.5%)
Total Long-term LiabilitiesHelp
(Percent)
10,843down
(6.2%)down
11,177down
(6.5%)down
11,445up
(6.8%)up
538up
(0.3%)up
376
(0.2%)
Shareholder's EquityHelp
(Percent)
125,461up
(71.3%)down
124,507down
(72.4%)down
124,661up
(74.6%)up
122,710down
(71.7%)up
123,395
(71.3%)
Total LiabilitiesHelp
(Percent)
176,045
(100%)
171,924
(100%)
167,126
(100%)
171,160
(100%)
173,034
(100%)

KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2023年3月期 KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2022年3月期 KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2021年3月期 KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2020年3月期 KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales
(Percent)
113,270
(100%)
105,534
(100%)
102,904
(100%)
109,983
(100%)
113,620
(100%)
Total Sales
(Percent)
113,270
(100%)
105,534
(100%)
102,904
(100%)
109,983
(100%)
113,620
(100%)
Cost of SalesHelp
(Percent)
63,102up
(55.7%)up
56,093up
(53.2%)up
51,276down
(49.8%)up
52,950down
(48.1%)down
56,210
(49.5%)
Other Costs and RevenueHelp 45,444down
(40.1%)down
45,509up
(43.1%)down
45,498down
(44.2%)down
50,884up
(46.3%)up
50,541
(44.5%)
Total CostsHelp 108,546 101,602 96,774 103,834 106,751
Net RevenueHelp 50,168up
(44.3%)down
49,441down
(46.8%)down
51,628down
(50.2%)down
57,033down
(51.9%)up
57,410
(50.5%)
Earnings Before TaxHelp 6,906up
(6.1%)up
5,216down
(4.9%)down
8,352up
(8.1%)up
8,255down
(7.5%)down
9,359
(8.2%)
Net IncomeHelp 4,724up
(4.2%)up
3,932down
(3.7%)down
6,130down
(6.0%)up
6,149down
(5.6%)down
6,869
(6.0%)
当期純利益 4,724 3,932 6,130 6,149 6,869

KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2023年3月期 KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2022年3月期 KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2021年3月期 KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2020年3月期 KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
1,924down
(20.0%)down
6,347up
(95.1%)up
5,187down
(56.3%)down
7,678up
(95.0%)up
341
(1.2%)
Investing Cash Flow(ICF)Help
(Percent)
-6,275down
(-65.1%)down
-2,560up
(-38.4%)up
-4,259down
(-46.2%)down
-2,943down
(-36.4%)down
14,939
(54.6%)
Financing Cash FlowHelp
(Percent)
-3,363up
(-34.9%)up
-4,112up
(-61.6%)down
-4,918up
(-53.3%)up
-5,117up
(-63.3%)up
-27,315
(-99.9%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
241up
(2.5%)up
139up
(2.1%)up
-43down
(-0.5%)down
-22
(-0.3%)down
-22
(-0.1%)
Net Increase and Decrease in Cash and Cash Equivalentsn -7,473down
(-77.5%)down
-186up
(-2.8%)up
-4,033down
(-43.7%)down
-404up
(-5.0%)up
-12,057
(-44.1%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

KYORIN Pharmaceutical Co., Ltd.

Company where related level is highHelp

BIOFERMIN PHARMACEUTICAL CO.,LTD.
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
HISAMITSU PHARMACEUTICAL CO.,INC.
KAINOS Laboratories,Inc.
ECI,Inc.
TSUMURA & CO.
Tsubota Laboratory Incorporated
RIBOMIC Inc.
Kubota Pharmaceutical Holdings Co.,Ltd.
MEDICAL & BIOLOGICAL LABORATORIES CO.